Greenwich LifeSciences (GLSI) Retained Earnings (2019 - 2026)

Greenwich LifeSciences (GLSI) has 7 years of Retained Earnings data on file, last reported at -$87.1 million in Q4 2025.

• Quarterly Retained Earnings fell 28.56% year-over-year to -$87.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$87.1 million (down 28.56% YoY) and the FY2025 annual result came in at -$87.1 million, down 28.56% from the prior year.
• Retained Earnings eased to -$87.1 million in Q4 2025, from -$77.6 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $59.6 million in Q2 2021 to a low of -$87.1 million in Q4 2025.
• A 5-year average of -$45.8 million and a median of -$46.4 million in 2023 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2021 — Retained Earnings decreased 12.04% — and 2022, when it sank 161.04%.
• Tracing GLSI's Retained Earnings over 5 years: stood at -$33.6 million in 2021, then slipped by 23.26% to -$41.5 million in 2022, then slipped by 21.44% to -$50.4 million in 2023, then plunged by 34.58% to -$67.8 million in 2024, then slipped by 28.56% to -$87.1 million in 2025.
• The last three Retained Earnings figures came in at -$87.1 million (Q4 2025), -$77.6 million (Q3 2025), and -$73.4 million (Q2 2025), per Business Quant data.